Alkem Laboratories slips 2.68% after Q2 profit falls 12%

Alkem Laboratories fell 2.68% on 12 November 2026 near its 100 DEMA, with resistance at 5510 and support at 4810. Alkem Laboratories Limited [ ALKEM ] fell 2.68% on 12 November 2026, ending a run of four straight winning sessions. The stock closed near its 100 DEMA. The September quarter numbers came in mixed. Consolidated net profit fell 11.8% year on year to Rs 675 crore from Rs 765 crore, as reported by IANS. Revenue from operations rose 13.8% to Rs 4,552 crore from Rs 4,001 crore. NDTV Profit also reported that the company named Gopal Kothari as chief financial officer. Sales growth is healthy. Profit falling despite it points to costs, the likely focus for investors. Total expenses rose 16%, faster than the 14.2% rise in total income, according to Free Press Journal. On the chart, the trend is sideways. Resistance sits at 5510 and support at 4810. The 100 DEMA is the nearby test. A close below it keeps the stock range-bound with a risk of a move toward 4810. A close above 5510 would end the sideways phase. Watch whether the stock holds the 100 DEMA in the next session. A sustained move beyond either level would change this view. Stance stays neutral inside 4810 to 5510. Disclosure: I do not hold any position in this stock. This is not a recommendation to buy or sell. Investments in securities markets are subject to market risks. Read all related documents carefully before investing.